|
YWHAB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.60880000005448E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.09259999994771E-06 |
| Normal-vs-Stage2 |
3.054300E-02 |
| Normal-vs-Stage3 |
2.138400E-01 |
| Normal-vs-Stage4 |
1.420040E-04 |
| Stage1-vs-Stage2 |
7.138600E-01 |
| Stage1-vs-Stage3 |
9.993800E-02 |
| Stage1-vs-Stage4 |
4.830000E-01 |
| Stage2-vs-Stage3 |
4.148000E-01 |
| Stage2-vs-Stage4 |
3.860600E-01 |
| Stage3-vs-Stage4 |
1.388750E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.76769999999027E-06 |
| Normal-vs-AfricanAmerican |
9.59689999999735E-05 |
| Normal-vs-Asian |
1.151660E-02 |
| Caucasian-vs-AfricanAmerican |
9.753600E-01 |
| Caucasian-vs-Asian |
8.269800E-01 |
| AfricanAmerican-vs-Asian |
8.010400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.91260000246419E-08 |
| Normal-vs-Female |
1.811800E-01 |
| Male-vs-Female |
2.606500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.63570000000824E-05 |
| Normal-vs-Extreme_Weight |
7.44860000345682E-08 |
| Normal-vs-Obese |
9.264500E-03 |
| Normal-vs-Extreme_Obese |
5.60869999999269E-05 |
| Normal_Weight-vs-Extreme_Weight |
4.750800E-01 |
| Normal_Weight-vs-Obese |
1.540570E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.592400E-01 |
| Extreme_Weight-vs-Obese |
1.656400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.679800E-01 |
| Obese-vs-Extreme_Obese |
6.598000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.100200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.637900E-04 |
| Normal-vs-Age(61-80Yrs) |
3.94269999981489E-07 |
| Normal-vs-Age(81-100Yrs) |
7.26939999973197E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.552000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.380570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.329900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.710100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.897000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.857700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.05310000053649E-07 |
| Normal-VS-Type2 PRCC |
4.03749999999814E-05 |
| Normal-VS-KIRP CIMP |
3.871600E-01 |
| Normal-VS-Unclassified PRCC |
8.067200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.602000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.337020E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.156030E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.352200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.772400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.506600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.00740000000366E-06 |
| Normal-vs-N1 |
1.633050E-01 |
| Normal-vs-N2 |
1.575570E-02 |
| N0-vs-N1 |
2.649700E-02 |
| N0-vs-N2 |
9.575800E-01 |
| N1-vs-N2 |
3.142200E-01 |
|
|
